The TH-Lac-A50 coated tablet was fu

The TH-Lac-A50 coated tablet was further applied to in vivo animal study, where the lactose was incorporated in the drug core and the composition of coating film was CA50%/PEG50%. Figure 5 shows the plasma drug concentration after intravenous injection of theophylline solution, oral administrations of uncoated (TH-Lac) and coated (TH-Lac-A50) theophylline tablets respectively.

結果 (繁體中文) 1:

對TH-紫膠-A50包衣片劑進一步應用於體內動物研究，其中乳糖與藥物核心併入並塗覆薄膜的組成為CA50％/ PEG50％。圖5顯示了茶鹼溶液的靜脈注射後的血漿藥物濃度，（-TH-紫膠A50）茶鹼片分別塗覆未塗覆（TH-LAC）的口服給藥和。

結果 (繁體中文) 2:

TH-Lac-A50塗層片劑進一步應用於體內動物研究，其中乳糖被納入藥物核心，塗層膜的成分為CA50%/PEG50%。圖5分別顯示了靜脈注射諾皮林溶液、口服未塗布（TH-Lac）和塗布（TH-Lac-A50）茶鹼片劑後的血漿藥物濃度。

結果 (繁體中文) 3:

將TH-Lac-A50包衣片進一步應用於體內動物實驗，將乳糖加入藥物覈心，包衣膜成分為CA50%/PEG50%。圖5顯示了靜脈注射茶鹼溶液、口服未塗層（TH-Lac）茶鹼片和塗層（TH-Lac-A50）茶鹼片後的血漿藥物濃度。